PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in PDS Biotechnology Corp as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −2 vs. Q4 2025
- Shares held
- 5.05M
- −882.4K (−14.9%) vs. Q4 2025
- Total value
- $3.05M
- −$1.51M (−33.1%) vs. Q4 2025
- New holders
- 7
- 11 more added
- Sold out
- 9
- 9 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PDSB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 52 | $6.78M |
| Q1 2026 | 41 | $3.05M |
| Q4 2025 | 44 | $6.07M |
| Q3 2025 | 47 | $5.32M |
| Q2 2025 | 55 | $9.90M |
| Q1 2025 | 48 | $9.81M |
| Q4 2024 | 52 | $6.94M |
| Q3 2024 | 57 | $16.6M |
| Q2 2024 | 77 | $16.1M |
| Q1 2024 | 72 | $30.2M |
| Q4 2023 | 77 | $41.6M |
| Q3 2023 | 78 | $39.7M |
| Q2 2023 | 80 | $39.9M |
| Q1 2023 | 69 | $46.9M |
| Q4 2022 | 64 | $90.0M |
| Q3 2022 | 47 | $15.4M |
| Q2 2022 | 52 | $19.7M |
| Q1 2022 | 53 | $36.7M |
| Q4 2021 | 66 | $48.3M |
| Q3 2021 | 60 | $101.0M |
| Q2 2021 | 46 | $74.4M |
| Q1 2021 | 32 | $14.3M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding PDS Biotechnology Corp; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 75 | $0 | 0.00% | +10+15.4% | Added |
| Beacon Investment Advisory Services, Inc. | 5 | $4 | 0.00% | +5 | New |
| JPMorgan Chase & Co | 19 | $10 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 118 | $71 | 0.00% | +9+8.3% | Added |
| Simplex Trading, LLC | 271 | $163 | 0.00% | −18,835−98.6% | Reduced |
| Basecamp Wealth Advisors LLC | 377 | $228 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 648 | $392 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 655 | $396 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 2,000 | $1.08K | 0.00% | 00.0% | Unchanged |
| Creative Financial Designs Inc | 3,000 | $1.81K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,567 | $2.16K | 0.00% | −355−9.1% | Reduced |
| Morgan Stanley | 3,922 | $2.37K | 0.00% | −1,000−20.3% | Reduced |
| Davenport & Co LLC | 10,000 | $6.05K | 0.00% | 00.0% | Unchanged |
| Grandfield & Dodd, LLC | 10,000 | $6.05K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 10,236 | $6.19K | 0.00% | −3,500−25.5% | Reduced |
| United Capital Financial Advisers, LLC | 12,000 | $7.26K | 0.00% | +12,000 | New |
| Vanguard Global Advisers, LLC | 12,546 | $7.59K | 0.00% | +12,546 | New |
| Wealth Group, Ltd. | 13,399 | $8.00K | 0.01% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 14,800 | $8.95K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 22,052 | $13.3K | 0.00% | −16,514−42.8% | Reduced |
| Rockefeller Capital Management L.P. | 27,664 | $16.7K | 0.00% | +2,000+7.8% | Added |
| ACT Capital Management, LLC | 30,000 | $18.1K | 0.01% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 31,481 | $19.0K | 0.00% | +31,481 | New |
| XTX Topco Ltd | 36,211 | $21.9K | 0.00% | +1,993+5.8% | Added |
| UBS Group AG | 56,004 | $33.9K | 0.00% | −195,701−77.8% | Reduced |
| Tempus Wealth Planning, LLC | 61,800 | $37.4K | 0.01% | 00.0% | Unchanged |
| Nine Masts Capital Ltd | 67,507 | $40.8K | 0.01% | +67,507 | New |
| Bank of New York Mellon Corp | 69,311 | $41.9K | 0.00% | 00.0% | Unchanged |
| Amussen Hunsaker Associates LLC | 75,022 | $45.4K | 0.00% | +60.0% | Added |
| Commonwealth Equity Services, LLC | 90,797 | $54.9K | 0.00% | −106,000−53.9% | Reduced |
| Northern Trust Corp | 108,893 | $65.9K | 0.00% | −34,980−24.3% | Reduced |
| Wells Fargo & Company | 110,500 | $66.9K | 0.00% | +105,171+1,973.6% | Added |
| State Street Corp | 133,333 | $80.7K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 173,605 | $105.0K | 0.00% | −2,660,901−93.9% | Reduced |
| Inspirion Wealth Advisors, LLC | 181,995 | $110.1K | 0.01% | +1,500+0.8% | Added |
| Renaissance Technologies LLC | 220,800 | $133.6K | 0.00% | +44,100+25.0% | Added |
| Blair William & Co | 300,000 | $181.5K | 0.00% | +50,000+20.0% | Added |
| Vanguard Fiduciary Trust Co | 307,311 | $185.9K | 0.00% | +307,311 | New |
| BlackRock, Inc. | 554,048 | $335.2K | 0.00% | +31,837+6.1% | Added |
| Geode Capital Management, LLC | 660,228 | $399.5K | 0.00% | +139,830+26.9% | Added |
| Vanguard Capital Management LLC | 1,631,089 | $986.8K | 0.00% | +1,631,089 | New |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −192,556−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −32,099−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −14,703−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −9,393−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,220−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,028−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |